CN111100085A - Preparation method of 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound - Google Patents

Preparation method of 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound Download PDF

Info

Publication number
CN111100085A
CN111100085A CN201911414178.XA CN201911414178A CN111100085A CN 111100085 A CN111100085 A CN 111100085A CN 201911414178 A CN201911414178 A CN 201911414178A CN 111100085 A CN111100085 A CN 111100085A
Authority
CN
China
Prior art keywords
compound
benzo
aryl
acid
aminophenol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911414178.XA
Other languages
Chinese (zh)
Other versions
CN111100085B (en
Inventor
姜国芳
陈国庆
谢宗波
乐长高
祝志强
陈中胜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East China Institute of Technology
Original Assignee
East China Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China Institute of Technology filed Critical East China Institute of Technology
Priority to CN201911414178.XA priority Critical patent/CN111100085B/en
Publication of CN111100085A publication Critical patent/CN111100085A/en
Application granted granted Critical
Publication of CN111100085B publication Critical patent/CN111100085B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a preparation method of a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound, which comprises the steps of taking a deep eutectic solvent as a reaction solvent for a reaction substrate 2-aminophenol compound and a keto acid compound, magnetically stirring the reaction solvent under an oil bath pan, carrying out post-treatment after the reaction is finished to obtain the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound, uniformly mixing choline chloride and urea in a molar ratio of 1: 2, and then heating the mixture to a uniform and transparent liquid at 80 ℃ to form the deep eutectic solvent.

Description

Preparation method of 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound
Technical Field
The invention relates to the field of organic synthesis, in particular to a preparation method of a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound.
Background
The 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound is an organic heterocyclic compound with photophysical and photochemical activity, antibacterial activity and antitumor activity, and as the potential application of the compound in material and pharmaceutical chemistry becomes more and more important, the development of efficient and green methodology for obtaining benzoxazine derivatives is very attractive.
Currently, several methods for preparing benzoxazine compounds are as follows:
synthesizing 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one by taking 2-aminophenol and keto acid as reaction substrates;
the ring opening of benzoxazole is reacted with keto acid compound to synthesize 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one;
however, the catalysts adopted by the two methods have the defects of insufficient environmental protection and limited substrate range, so that the development of a green preparation method with wider application range has positive significance.
Disclosure of Invention
The invention aims to solve the defects in the prior art and provides a preparation method of a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound, which has the advantages of simple operation process, mild reaction conditions, low cost, environmental protection and popularization and application value.
A process for the preparation of a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound comprising:
taking a deep eutectic solvent as a reaction solvent for the reaction substrate 2-aminophenol compound and the ketonic acid compound, magnetically stirring under an oil bath pan, and carrying out post-treatment after the reaction is finished to obtain a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-ketone compound;
the deep eutectic solvent is prepared from choline chloride and urea in a molar ratio of 1: 2 and then heating to a uniform, transparent liquid at 80 ℃.
Further, the preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound is as follows, and the structural formula of the 2-aminophenol compound is as follows:
Figure BDA0002350751780000021
wherein R is selected from H, an electron withdrawing group or an electron donating group.
Further, the preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound is as follows:
Figure BDA0002350751780000022
wherein R is1Selected from H, electron withdrawing groups or electron donating groups.
Further, the preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound is as described above, the electron-withdrawing group of the 2-aminophenol compound comprises halogen, and the electron-donating group comprises methyl.
Further, the method for producing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound as described above, wherein the 2-aminophenol compound is any one of 2-aminophenol, 4-chloro-2-aminophenol and 5-methyl-2-aminophenol.
Furthermore, the preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound comprises the steps that the electron-withdrawing group of the keto acid compound comprises halogen, and the electron-donating group comprises methyl and methoxy.
Further, the preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound is any one of 4-fluorobenzoylformic acid, 4-chlorobenzoylformic acid, 4-bromobenzoylformic acid, 2-bromobenzoylformic acid, 4-methylbenzoylformic acid, 4-methoxybenzoylformic acid and α -oxo-2-furanacetic acid.
Further, the preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound is characterized in that the reaction is carried out in an oil bath kettle at the temperature of 80 ℃ by magnetic stirring, and the reaction time is not less than 0.5H.
Further, in the above-mentioned method for producing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound, the molar ratio of the 2-aminophenol compound to the keto acid compound as a reaction substrate is 1: 2.
Further, the post-treatment of the preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound comprises purification and drying, wherein the purification adopts column chromatography separation, and the drying adopts vacuum drying, and the drying temperature is 30 ℃.
The preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-ketone compound solves the problem that the catalyst used in the existing reaction is not environment-friendly, and has the following advantages:
(1) the preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound provided by the invention adopts a deep eutectic solvent as a reaction solvent, does not need other organic solvents or any other catalysts, is green and environment-friendly, and has the advantages of cheap and easily-obtained reaction solvent synthesis method and low cost, thereby being a novel method for synthesizing the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound.
(2) The preparation method of the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound provided by the invention is green and efficient, few in byproducts, easy to separate the target product, green and environment-friendly in the whole process, and compared with the traditional chemical catalysis method, the yield of the target product synthesized in a deep eutectic solvent is higher, and the reaction conditions are more environment-friendly.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions of the present invention are described clearly and completely below, and it is obvious that the described embodiments are some, not all embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A preparation method of 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound comprises the following synthetic route:
Figure BDA0002350751780000041
the method specifically comprises the following steps:
(1) taking a 10mL reaction bottle, adding 0.2mmol of 2-aminophenol, 0.4mmol of benzoylformic acid and 2mL of deep eutectic solvent (the molar ratio of choline chloride to urea is 1: 2);
(2) placing the reaction bottle in the step (1) under an oil bath pan at 80 ℃ for magnetic stirring, and reacting for 2 hours to obtain a crude product;
(3) and (3) carrying out column chromatography separation on the crude product obtained in the step (2), wherein the eluent is a mixed solution of ethyl acetate and petroleum ether with the volume ratio of 1: 6, and drying at 30 ℃ for 3H to obtain the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound.
And (3) performing nuclear magnetic resonance hydrogen spectrum determination on the prepared target product:
1H NMR(500MHz,DMSO)δ8.19(d,J=6.9Hz,2H),7.84(d,J=6.8Hz,1H),7.63–7.50(m,4H),7.44(dd,J=11.5,4.5Hz,2H).13C NMR(126MHz,DMSO):δ152.54,151.82,146.82,134.85,131.78,131.54,131.45,129.77,129.35,128.55,125.85,116.52。
example 2
Figure BDA0002350751780000042
A preparation method of a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound specifically comprises the following steps:
(1) taking a 10mL reaction bottle, adding 0.2mmol of 4-chloro-2-aminophenol, 0.4mmol of benzoylformic acid and 2mL of deep eutectic solvent (the molar ratio of choline chloride to urea is 1: 2);
(2) placing the reaction bottle in the step (1) under an oil bath pan at 80 ℃ for magnetic stirring, and reacting for 2 hours to obtain a crude product;
(3) and (3) carrying out column chromatography separation on the crude product obtained in the step (2), wherein the eluent is a mixed solution of ethyl acetate and petroleum ether with the volume ratio of 1: 6, and drying at 30 ℃ for 3H to obtain the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound.
And (3) performing nuclear magnetic resonance hydrogen spectrum determination on the prepared target product:
1H NMR(500MHz,DMSO)δ8.19(d,J=7.2Hz,2H),7.91(d,J=2.4Hz,1H),7.64(dd,J=8.8,2.4Hz,1H),7.61–7.47(m,4H)。13C NMR(126MHz,CDCl3)δ151.94,151.84,145.18,133.87,132.31,132.04,131.13,130.84,129.75,129.00,128.62,117.43.
example 3
Figure BDA0002350751780000051
A preparation method of a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound specifically comprises the following steps:
(1) taking a 10mL reaction bottle, adding 0.2mmol of 5-methyl-2-aminophenol, 0.4mmol of benzoylformic acid and 2mL of deep eutectic solvent (the molar ratio of choline chloride to urea is 1: 2);
(2) placing the reaction bottle in the step (1) under an oil bath pan at 80 ℃ for magnetic stirring, and reacting for 2 hours to obtain a crude product;
(3) and (3) carrying out column chromatography separation on the crude product obtained in the step (2), wherein the eluent is a mixed solution of ethyl acetate and petroleum ether with the volume ratio of 1: 6, and drying at 30 ℃ for 3H to obtain the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound.
And (3) performing nuclear magnetic resonance hydrogen spectrum and carbon spectrum determination on the prepared target product:
1H NMR(500MHz,CDCl3)δ8.31(d,J=2.9Hz,2H),7.71(d,J=8.1Hz,1H),7.49(dd,J=12.8,5.3Hz,3H),7.19(d,J=8.1Hz,1H),7.12(s,1H),2.48(s,3H)。13C NMR(126MHz,CDCl3)δ152.58,149.67,146.48,142.65,134.40,131.25,129.81,129.42,129.12,128.44,126.82,116.32,21.87.
example 4
Figure BDA0002350751780000052
A preparation method of a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound specifically comprises the following steps:
(1) taking a 10mL reaction bottle, adding 0.2mmol of 2-aminophenol, 0.4mmol of 4-chlorobenzoyl formic acid and 2mL of deep eutectic solvent (the mol ratio of choline chloride to urea is 1: 2);
(2) placing the reaction bottle in the step (1) under an oil bath pan at 80 ℃ for magnetic stirring, and reacting for 2 hours to obtain a crude product;
(3) and (3) carrying out column chromatography separation on the crude product obtained in the step (2), wherein the eluent is a mixed solution of ethyl acetate and petroleum ether with the volume ratio of 1: 6, and drying at 30 ℃ for 3H to obtain the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound.
And (3) performing nuclear magnetic resonance hydrogen spectrum and carbon spectrum determination on the prepared target product:
1H NMR(500MHz,CDCl3)δ8.34(d,J=8.7Hz,2H),7.84(d,J=9.4Hz,1H),7.53(t,J=7.8Hz,1H),7.46(d,J=8.7Hz,2H),7.40(t,J=8.3Hz,1H),7.34(d,J=8.2Hz,1H).13CNMR(126MHz,CDCl3):δ152.30,149.60,146.59,137.99,132.61,131.67,131.54,130.96,129.61,128.80,125.84,116.35。
example 5
Figure BDA0002350751780000061
A preparation method of a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound specifically comprises the following steps:
(1) taking a 10mL reaction bottle, adding 0.2mmol of 2-aminophenol, 0.4mmol of 4-methylbenzoyl formic acid and 2mL of deep eutectic solvent (the molar ratio of choline chloride to urea is 1: 2);
(2) placing the reaction bottle in the step (1) under an oil bath pan at 80 ℃ for magnetic stirring, and reacting for 2 hours to obtain a crude product;
(3) and (3) carrying out column chromatography separation on the crude product obtained in the step (2), wherein the eluent is a mixed solution of ethyl acetate and petroleum ether with the volume ratio of 1: 6, and drying at 30 ℃ for 3H to obtain the 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound.
And (3) performing nuclear magnetic resonance hydrogen spectrum and carbon spectrum determination on the prepared target product:
1H NMR(500MHz,CDCl3)δ8.26(d,J=8.3Hz,2H),7.84(d,J=9.3Hz,1H),7.50(t,J=8.5Hz,1H),7.38(t,J=7.7Hz,1H),7.32(t,J=9.3Hz,3H),2.46(s,3H).13C NMR(126MHz,CDCl3):δ152.52,150.85,146.56,142.19,131.87,131.60,130.96,129.59,129.45,129.30,125.65,116.27,21.73。
as can be seen from Table 1, the effect of the reaction substrate on the yield of 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound synthesized by the present invention is best seen in that the reaction substrate has the best effect on the production of benzoylformic acid having an electron-withdrawing group, such as fluorine, chlorine and bromine, with the highest and substantially constant yield and the electron-donating group has the lowest yield of p-methoxy group, and Table 1 shows that the different substrates have the lowest yields for the synthesis of 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound
Figure BDA0002350751780000071
Finally, it should be noted that: the above examples are only intended to illustrate the technical solution of the present invention, but not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions of the embodiments of the present invention.

Claims (10)

1. A process for preparing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound comprising:
taking a deep eutectic solvent as a reaction solvent for the reaction substrate 2-aminophenol compound and the ketonic acid compound, magnetically stirring under an oil bath pan, and carrying out post-treatment after the reaction is finished to obtain a 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-ketone compound;
the deep eutectic solvent is prepared from choline chloride and urea in a molar ratio of 1: 2 and then heating to a uniform, transparent liquid at 80 ℃.
2. The process for preparing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound according to claim 1, wherein the 2-aminophenol compound has the formula:
Figure FDA0002350751770000011
wherein R is selected from H, an electron withdrawing group or an electron donating group.
3. The method of preparing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound according to claim 1, wherein the ketoacid compound has the structural formula:
Figure FDA0002350751770000012
wherein R is1Selected from H, electron withdrawing groups or electron donating groups.
4. The method for producing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound according to claim 2, wherein the electron-withdrawing group of the 2-aminophenol compound comprises a halogen and the electron-donating group comprises a methyl group.
5. The method for producing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound according to claim 4, wherein the 2-aminophenol compound is any one of 2-aminophenol, 4-chloro-2-aminophenol and 5-methyl-2-aminophenol.
6. The method of claim 3, wherein said keto acid compound comprises a halogen and said electron-donating group comprises a methyl group or a methoxy group.
7. The method for producing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound according to claim 6, wherein the keto acid compound is any one of 4-fluorobenzoylformic acid, 4-chlorobenzoylformic acid, 4-bromobenzoylformic acid, 2-bromobenzoylformic acid, 4-methylbenzoylformic acid, 4-methoxybenzoylformic acid, and α -oxo-2-furanacetic acid.
8. The process for producing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound according to claim 1, wherein the reaction is carried out by magnetic stirring in an oil bath at 80 ℃ for a reaction time of not less than 0.5 hour.
9. The method for producing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound according to claim 1, wherein the molar ratio of the 2-aminophenol compound to the keto acid compound as the reaction substrate is 1: 2.
10. The process for producing a 3-aryl-2H-benzo [ β ] [1,4] benzoxazin-2-one compound according to claim 1, wherein the post-treatment comprises purification by column chromatography and drying by vacuum drying at 30 ℃.
CN201911414178.XA 2019-12-31 2019-12-31 Preparation method of 3-aryl-2H-benzo [ beta ] [1,4] benzoxazine-2-one compound Active CN111100085B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911414178.XA CN111100085B (en) 2019-12-31 2019-12-31 Preparation method of 3-aryl-2H-benzo [ beta ] [1,4] benzoxazine-2-one compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911414178.XA CN111100085B (en) 2019-12-31 2019-12-31 Preparation method of 3-aryl-2H-benzo [ beta ] [1,4] benzoxazine-2-one compound

Publications (2)

Publication Number Publication Date
CN111100085A true CN111100085A (en) 2020-05-05
CN111100085B CN111100085B (en) 2023-07-28

Family

ID=70425580

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911414178.XA Active CN111100085B (en) 2019-12-31 2019-12-31 Preparation method of 3-aryl-2H-benzo [ beta ] [1,4] benzoxazine-2-one compound

Country Status (1)

Country Link
CN (1) CN111100085B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111943924A (en) * 2020-07-31 2020-11-17 吉林警察学院 Synthesis method of chromanone compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108129399A (en) * 2018-02-13 2018-06-08 大连大学 The synthetic method of -2 (1H) -one of 4- aryl -5- methoxycarbonyl group -6- methyl -3,4- dihydro-pyrimidins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108129399A (en) * 2018-02-13 2018-06-08 大连大学 The synthetic method of -2 (1H) -one of 4- aryl -5- methoxycarbonyl group -6- methyl -3,4- dihydro-pyrimidins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
冯柏成等: "深共熔溶剂中β-二羰基化合物的α-酰基化", 《精细化工》 *
卢粤等: "深共熔溶剂法合成喹啉衍生物", 《精细化工》 *
陈国庆等: "深共融溶剂中合成2,4-二取代喹啉衍生物", 《有机化学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111943924A (en) * 2020-07-31 2020-11-17 吉林警察学院 Synthesis method of chromanone compounds
CN111943924B (en) * 2020-07-31 2023-03-28 吉林警察学院 Synthesis method of chromanone compounds

Also Published As

Publication number Publication date
CN111100085B (en) 2023-07-28

Similar Documents

Publication Publication Date Title
CN112898192B (en) Preparation method of N-acyl indole compound
CN105772094A (en) Chiral nitrogen heterocycle carbene type catalyst and application thereof
CN108314658B (en) A kind of preparation method of polysubstituted oxazole derivatives
CN111100085A (en) Preparation method of 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound
CN113735778A (en) Preparation method of 5-trifluoromethyl substituted imidazole compound
CN115772157B (en) Preparation method of 2-alkoxyindole compound
JP2009227673A (en) Method for producing chiral dihydrobenzofuranes compound and catalyst for use in the same
CN110922369A (en) Trifluoromethyl substituted dihydrofuran amine compound and preparation method and application thereof
CN114773301B (en) Method for synthesizing furan compounds from terminal alkyne and iodoylide
CN114380790B (en) Polysubstituted thiopyran derivative and synthetic method thereof
CN114989178A (en) Spiro [ beta-lactam-3, 3' -oxindole ] derivative and preparation method and application thereof
CN110015999B (en) Synthesis method of 1,2, 3-triazole compound
CN106854125B (en) Method for preparing α -fluoro- β -ethynyl ketone compound containing two chiral centers
CN115340460B (en) Synthesis method of Reissert indole synthesis reaction intermediate
CN114181182B (en) Synthesis method of polysubstituted 4H-pyran compound
CN108101758B (en) Method for preparing chiral propargylated aliphatic six-membered carbocyclic ring compound
CN107459530A (en) A kind of 1,3 isoquinolin derovatives of novel silicon base substitution and preparation method thereof
CN116813525B (en) Synthesis method of polyacetyl substituted oxindole compound
CN113200980B (en) Method for synthesizing indolizine compound under catalysis of silver
CN113461690B (en) Synthesis method of chiral 4,6-dioxooctahydropyrrolo [3,4-c ] pyrrole-1-carboxylate compound
CN109988114B (en) Preparation method of polysubstituted 4, 5-dihydropyrazole compound
CN111732541B (en) Method for efficiently synthesizing 6-alkenyl phenanthridine derivative through ruthenium-catalyzed C-H activation/cyclization reaction
CN109320554B (en) Novel method for synthesizing practical acetaminoacrylate compound
CN111892582B (en) Preparation method of benzofuran coumarin compound
CN112441934B (en) Halogenated oxaallylamine compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant